Manuscripts
Showing 1533 manuscripts.
Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents.
Citation
Juan Carlos Salazar, Pedro E. Cahn, Ram Yogev, Marinella Della Negra, Guido Castelli-Gattinara, Claudia Fortuny, Patricia M. Flynn, Carlo Giaquinto, Ping Ruan, Elizabeth (Betsy) Smith, Jaromir Mikl, Hernan Valdez, Ante Jelaska. Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents.. AIDS. 2008. 22: 1789-98. PMID: 18753862Year
2008
Journal
AIDS
Study
P1051
Toxicities associated with dual NRTI regimens in HIV-infected children
Citation
Russell B. Van Dyke, Lu Wang, Paige L. Williams. Toxicities associated with dual NRTI regimens in HIV-infected children. Journal of Infectious Diseases. 2008. 198: 1599-608. PMID: 19000014Year
2008
Journal
Journal of Infectious Diseases
Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy
Citation
Allison George Agwu, Jane C. Lindsey, Kimberly Ferguson, Haili Zhang, Stephen A. Spector, Bret J. Rudy, Steven D. Douglas, Patricia M. Flynn, Deborah Persaud. Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy. AIDS Patient Care and STDs. 2008. 22: 545-52. PMID: 18479228Year
2008
Journal
AIDS Patient Care and STDs
Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C
Citation
Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C. Journal of Clinical Microbiology. 2008. 46: 2945-9. PMID: 18614660Year
2008
Journal
Journal of Clinical Microbiology
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics
Citation
Marlene Smurzynski, Ann C. Collier, Susan L. Koletar, Ronald J. Bosch, Kunling Wu, Barbara Bastow, Constance A. Benson. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. HIV Clinical Trials. 2008. 9: 269-82.Year
2008
Journal
HIV Clinical Trials
Improved measures of quality of life, lipid profile and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170
Citation
Daniel J. Skiest, Amy Krambrink, Zhaohui Su, Kevin R. Robertson, David M. Margolis. Improved measures of quality of life, lipid profile and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170. Journal of Acquired Immune Deficiency Syndromes. 2008. 49: 377-83.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients
Citation
Lisa M. Demeter, Lisa Mukherjee, Robin DiFrancesco, Hongyu Jiang, Robert DiCenzo, Barbara Bastow, Alex R. Rinehart, Gene D. Morse, Mary Albrecht. The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients. HIV Clinical Trials. 2008. 9: 61-72.Year
2008
Journal
HIV Clinical Trials
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy
Citation
Jeffrey A. Canter, David W. Haas, Asha R. Kallianpur, Marylyn D. Ritchie, Gregory K. Robbins, Robert Shafer, David B. Clifford, Deborah G. Murdock, Todd Hulgan. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics. 2008. 8: 71-7.Year
2008
Journal
Pharmacogenomics
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis
Citation
Christina M. Marra, Andrea Antinori, Andrea De Luca, Adriana Ammassari, Patrizio Pezzotti, Paola Cinque, Jacques Gasnault, Juan Berenguer, Simona Di Giambenedetto, Antonella Cingolani, Yassine Taofik, Rosa Pedale, Pilar Piralles, Dora Larussa, Subir Sinha, Roberto Cauda. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS. 2008. 22: 1759-67.Year
2008
Journal
AIDS
Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG study A5152s
Citation
James H. Stein, Lauren Komarow, Bruno R. Cotter, Judith Silverstein Currier, Michael P. Dube, Carl J. Fichtenbaum, Mariana Gerschenson, Carol K. Mitchell, Robert L. Murphy, Kathleen E. Squires, Robert A. Parker, Francesca J. Torriani. Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG study A5152s. Journal of Clinical Lipidology. 2008. 2: 464-71. PMID: 19956354Year
2008
Journal
Journal of Clinical Lipidology